Search Results - "FABER, L. M"

Hestia criteria can safely select patients with pulmonary embolism for outpatient treatment irrespective of right ventricular function by Zondag, W., Vingerhoets, L. M. A., Durian, M. F., Dolsma, A., Faber, L. M., Hiddinga, B. I., Hofstee, H. M. A., Hoogerbrugge, A. D. M., Hovens, M. M. C., Labots, G., Vlasveld, T., Vreede, M. J. M., Kroft, L. J. M., Huisman, M. V.

“…Summary Background There has been debate over how patients with pulmonary embolism (PE) can be safely selected for outpatient treatment. Objectives To compare…”
Get full text

Outpatient treatment in patients with acute pulmonary embolism: the Hestia Study by ZONDAG, W., MOS, I. C. M., CREEMERS‐SCHILD, D., HOOGERBRUGGE, A. D. M., DEKKERS, O. M., DOLSMA, J., EIJSVOGEL, M., FABER, L. M., HOFSTEE, H. M. A., HOVENS, M. M. C., JONKERS, G. J. P. M., van KRALINGEN, K. W., KRUIP, M. J. H. A., VLASVELD, T., DE VREEDE, M. J. M., HUISMAN, M. V.

“…Background: Traditionally, patients with pulmonary embolism (PE) are initially treated in the hospital with low molecular weight heparin (LMWH). The results of…”
Get full text

Hepatitis E during lenalidomide treatment for multiple myeloma in complete remission by Kootte, R S, Faber, L M

“…Lenalidomide has a central role in the treatment of multiple myeloma and results in improved survival. As with other chemotherapeutics, it can cause several…”
Get full text

Lipegfilgrastim for prophylaxis of chemotherapy-induced neutropenia in Dutch patients by Timmer-Bonte, J N H, Ouwerkerk, J, Faber, L M, Kerkhofs, L G M, Laterveer, L, Ten Oever, D, van Rees, B P, van der Linden, P W

“…BACKGROUNDChemotherapy (CT)-induced neutropenia and febrile neutropenia (FN) can lead to changes in the treatment plan, potentially worsening the cancer…”
Get full text

No added value of the age‐adjusted D‐dimer cut‐off to the YEARS algorithm in patients with suspected pulmonary embolism by Pol, L. M., Hulle, T., Cheung, Y. W., Mairuhu, A. T. A., Schaar, C. G., Faber, L. M., Wolde, M., Hofstee, H. M. A., Hovens, M. M. C., Nijkeuter, M., Klink, R. C. J., Kruip, M. J. H. A., Middeldorp, S., Huisman, M. V., Klok, F. A.

“…Essentials Imaging is warranted in the majority of patients to confirm or rule out pulmonary embolism (PE). The age‐adjusted D‐dimer (ADJUST) reduced the…”
Get full text

An elderly man with swelling and discolouration of the right earlobe by Kleijwegt, F S, van Krimpen, C, Faber, L M

Get full text

Generation of CD4+ cytotoxic T-lymphocyte clones from a patient with severe graft-versus-host disease after allogeneic bone marrow transplantation : implications for graft-versus-leukemia reactivity by FABER, L. M, VAN LUXEMBURG-HEIJS, S. A. P, VEENHOF, W. F. J, WILLEMZE, R, FALKENBURG, J. H. F

“…HLA-identical bone marrow transplantation (BMT) is associated with both graft-versus-host disease (GVHD) and graft-versus-leukemia (GVL) reactivity. Different…”
Get full text

Two Dutch families with hereditary hyperferritinaemia-cataract syndrome and heterozygosity for an HFE-related haemochromatosis gene mutation by SIMSEK, S, NANAYAKKARA, P. W. B, KEEK, J. M. F, FABER, L. M, BRUIN, K. F, PALS, G

“…Hereditary haemochromatosis is an autosomal recessive disorder, leading to progressive iron overload, which is very common among the Caucasian population. In…”
Get full text

Cost analysis of CHOP (‐like) chemotherapy regimens for patients with newly diagnosed aggressive non‐Hodgkin's lymphoma by Van Agthoven, M., Faber, L.M., Uyl‐de Groot, C.A., Sonneveld, P., Verdonck, L.F., Willemze, R., Kluin‐Nelemans, J.C., Löwenberg, B., Huijgens, P.C.

“…: Many cost analyses of stem‐cell transplantations are available, which is in sharp contrast to the level of cost analyses on first‐line chemotherapy for…”
Get full text

Generation of donor-derived antileukemic cytotoxic T-lymphocyte responses for treatment of relapsed leukemia after allogeneic HLA-identical bone marrow transplantation by Falkenburg, J H, Faber, L M, van den Elshout, M, van Luxemburg-Heijs, S A, Hooftman-den Otter, A, Smit, W M, Voogt, P J, Willemze, R

“…Allogeneic bone marrow transplantation (BMT) has been associated with an antileukemic effect, the graft-versus-leukemia (GVL) reactivity. Since T-cell…”
Get more information

An unusual late manifestation of a Salmonella typhi infection by Faber, L M, Simoons-Smith, A M, Razenberg, P P

“…We report the case history of a patient in whom we diagnosed purulent lymphadenitis due to Salmonella typhi, a late complication of a febris typhoidea that…”
Get more information

Predicting bleeding risk in frail older patients with atrial fibrillation using data from the FRAIL-AF trial by Van Doorn, S, Joosten, L P T, Kohlen, B T G, Nierman, M C, Koek, H L, Hemels, M E W, Huisman, M V, Kruip, M, Faber, L M, Wiersma, N M, Buding, W F, Adriaansen, H J, Rutten, F H, Geersing, G J

“…Abstract Background Bleeding remains an important complication in anticoagulated patients with atrial fibrillation (AF). Hereto, multiple scores have been…”
Get full text

Quality of life when switching from a vitamin K antagonist to non-vitamin K antagonist oral anticoagulation in frail older patients with atrial fibrillation by Van Doorn, S, Joosten, L P T, Kohlen, B T G, Nierman, M C, Koek, H L, Hemels, M E W, Huisman, M V, Kruip, M, Faber, L M, Wiersma, N M, Buding, W F, Adriaansen, H J, Rutten, F H, Geersing, G J

“…Abstract Background Many older patients with atrial fibrillation (AF) are frail, putting them at high risk of adverse outcomes including mortality,…”
Get full text

Recognition of clonogenic leukemic cells, remission bone marrow and HLA-identical donor bone marrow by CD8+ or CD4+ minor histocompatibility antigen-specific cytotoxic T lymphocytes by Faber, L M, van der Hoeven, J, Goulmy, E, Hooftman-den Otter, A L, van Luxemburg-Heijs, S A, Willemze, R, Falkenburg, J H

“…We investigated whether minor histocompatibility (mH) antigen-specific cytotoxic T lymphocytes (CTL) can discriminate between leukemic hematopoietic progenitor…”
Get full text

Life-prolonging treatment restrictions and outcomes in patients with cancer and COVID-19: an update from the Dutch Oncology COVID-19 Consortium by de Joode, Karlijn, Tol, Jolien, Hamberg, Paul, Cloos, Marissa, Kastelijn, Elisabeth A., Borgers, Jessica S.W., Nuij, Veerle J.A.A., Klaver, Yarne, Herder, Gerarda J.M., Mutsaers, Pim G.N.J., Dumoulin, Daphne W., Oomen-de Hoop, Esther, van Diemen, Nico G.J., Libourel, Eduard J., Geraedts, Erica J., Bootsma, Gerben P., van der Leest, Cor H., Peerdeman, Anne L., Herbschleb, Karin H., Visser, Otto J., Bloemendal, Haiko J., van Laarhoven, Hanneke W.M., de Vries, Elisabeth G.E., Hendriks, Lizza E.L., Beerepoot, Laurens V., Westgeest, Hans M., van den Berkmortel, Franchette W.P.J., Haanen, John B.A.G., Dingemans, Anne-Marie C., van der Veldt, Astrid A.M., Becker-Commissaris, A., Terheggen, F., van den Borne, B.E.E.M., van Warmerdam, L.J.C., van Leeuwen, L., van der Meer, F.S., Tiemessen, M.A., van Diepen, D.M., Strobbe, L., Koekkoek, J.A.F., Brocken, P., Drooger, J.C., Heller, R., de Groot, J.W.B., Stigt, J.A., Pitz, C.C.M., Slingerland, M., Borm, F.J., Haberkorn, B.C.M., van 't Westeinde, S.C., Aarts, M.J.B., van Putten, J.W.G., Youssef, M., Cirkel, G.A., van Rooijen, C.R., Citgez, E., Barlo, N.P., Scholtes, B.M.J., Koornstra, R.H.T., Claessens, N.J.M., Faber, L.M., Rikers, C.H., van de Wetering, R.A.W., Veurink, G.L., Bouter, B.W., Houtenbos, I., Bard, M.P.L., Douma, G., Jalving, M., Hiltermann, T.J.N., Schuurbiers-Siebers, O.C.J., Suijkerbuijk, K.P.M., van Lindert, A.S.R., van de Wouw, A.J., van den Boogaart, V.E.M., Bakker, S.D., Looysen, E., de Jong, W.K., Siemerink, E.J.M., Staal, A.J., Franken, B., van Geffen, W.H.

“…The coronavirus disease 2019 (COVID-19) pandemic significantly impacted cancer care. In this study, clinical patient characteristics related to COVID-19…”
Get full text

Generation of leukemia-reactive cytotoxic T lymphocyte clones from the HLA-identical bone marrow donor of a patient with leukemia by FABER, L. M, VAN LUXEMBURG-HEIJS, S. A. P, WILLEMZE, R, FALKENBURG, J. H. F

“…Allogeneic bone marrow transplantation (BMT) has been associated with a graft-vs.-leukemia (GVL) reactivity. Since T cell depletion of the bone marrow graft…”
Get full text

A single immunization with a recombinant canine adenovirus expressing the rabies virus G protein confers protective immunity against rabies in mice by Li, Jianwei, Faber, Milosz, Papaneri, Amy, Faber, Marie-Luise, McGettigan, James P., Schnell, Matthias J., Dietzschold, Bernhard

“…Rabies vaccines based on live attenuated rabies viruses or recombinant pox viruses expressing the rabies virus (RV) glycoprotein (G) hold the greatest promise…”
Get full text

Phase 1/2 study of lenalidomide combined with low-dose cyclophosphamide and prednisone in lenalidomide-refractory multiple myeloma by Nijhof, Inger S., Franssen, Laurens E., Levin, Mark-David, Bos, Gerard M.J., Broijl, Annemiek, Klein, Saskia K., Koene, Harry R., Bloem, Andries C., Beeker, Aart, Faber, Laura M., van der Spek, Ellen, Ypma, Paula F., Raymakers, Reinier, van Spronsen, Dick-Johan, Westerweel, Peter E., Oostvogels, Rimke, van Velzen, Jeroen, van Kessel, Berris, Mutis, Tuna, Sonneveld, Pieter, Zweegman, Sonja, Lokhorst, Henk M., van de Donk, Niels W.C.J.

“…The prognosis of multiple myeloma (MM) patients who become refractory to lenalidomide and bortezomib is very poor, indicating the need for new therapeutic…”
Get full text

Citrate haemodialysis by Faber, L M, de Vries, P M, Oe, P L, van der Meulen, J, Donker, A J

“…We describe our experience with sodium citrate as anticoagulant in the haemodialysis of 15 patients who were at high risk for bleeding. Furthermore, in six of…”
Get more information

A Single Amino Acid Change in Rabies Virus Glycoprotein Increases Virus Spread and Enhances Virus Pathogenicity by FABER, Milosz, FABER, Marie-Luise, PAPANERI, Amy, BETTE, Michael, WEIHE, Eberhard, DIETZSCHOLD, Bernhard, SCHNELL, Matthias J

“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text